In summary, our results indicate that the chemokine CXCL1 is upregulated prior to the inflammatory process and responds better to early aggressive treatment, which is consistent with the role of CXCL13 in SLE reported in previous studies [4, 20]. The gene discussed is CXCL13; the disease is systemic lupus erythematosus.